Alfa Chemistry Materials 5 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| 8arm-PEG20K-COOH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH, tripentaerythritol core, 8arm-PEG-COOH. Molecular formula: average Mn 20000. |  |
| 8arm-PEG20K-Maleimide | 8arm-PEG20K-Maleimide. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-NH2, hexaglycerol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, hexaglycerol core, 8arm-PEG-NH2. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-NH2, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, 8arm-PEG-NH2, tripentaerythritol core. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-Norbornene, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Norbornene, tripentaerythritol core, 8arm-PEG-NB. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-SH, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH, tripentaerythritol core, 8arm-PEG-SH. Molecular formula: average Mn 20000. | |
| 8arm-PEG20K-Succinimidyl Glutarate | 8arm-PEG20K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Succinimidyl Succinate | 8arm-PEG20K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Vinylsulfone, tripentaerythritol core | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-VS, 8arm-PEG-Vinylsulfone, tripentaerythritol core. Molecular formula: average Mn 20000. | |
| 8arm-PEG40K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2. Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| 8-arm PEG5K-Acrylate (hexaglycerol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Acrylate (tripentaerythritol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Methacrylate (hexaglycerol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-Methacrylate (tripentaerythritol core) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 8-arm PEG5K-PCL1K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8-arm PEG5K-PLA1K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). ≥95%. | |
| 8-Bromo-5H-pyrido[3,2-b]indole | 8-Bromo-5H-pyrido[3,2-b]indole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1236349-67-9. Product ID: 8-bromo-5H-pyrido[3,2-b]indole. Molecular formula: 247.1. Mole weight: C11H7BrN2. C1=CC2=C(C3=C(N2)C=CC(=C3)Br)N=C1. InChI=1S/C11H7BrN2/c12-7-3-4-9-8 (6-7)11-10 (14-9)2-1-5-13-11/h1-6, 14H. OXYFZHUGVBINOL-UHFFFAOYSA-N. >97.0%(HPLC). | |
| [8]Cycloparaphenylene | [8]Cycloparaphenylene. Group: Supramolecular host materials carbon nano materials. CAS No. 1217269-85-6. Product ID: nonacyclo[28.2.2.22, 5.26, 9.210, 13.214, 17.218, 21.222, 25.226, 29]octatetraconta-1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47-tetracosaene. Molecular formula: 608.8g/mol. Mole weight: C48H32. C1=CC2=C3C=CC (=C4C=CC (=C5C=CC (=C6C=CC (=C7C=CC (=C8C=CC (=C9C=CC (=C1C=C2) C=C9) C=C8) C=C7) C=C6) C=C5) C=C4) C=C3. InChI=1S/C48H32/c1-2-34-4-3-33 (1)35-5-7-37 (8-6-35)39-13-15-41 (16-14-39)43-21-23-45 (24-22-43)47-29-31-48 (32-30-47)46-27-25-44 (26-28-46)42-19-17-40 (18-20-42)38-11-9-36 (34)10-12-38/h1-32H. KOSJMHFAWQDZFH-UHFFFAOYSA-N. | |
| [8]Cycloparaphenylene, 95% | [8]Cycloparaphenylene, 95%. Group: Carbon nano materials. CAS No. 1217269-85-6. Product ID: nonacyclo[28.2.2.22, 5.26, 9.210, 13.214, 17.218, 21.222, 25.226, 29]octatetraconta-1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47-tetracosaene. Molecular formula: 608.8g/mol. Mole weight: C48H32. C1=CC2=C3C=CC (=C4C=CC (=C5C=CC (=C6C=CC (=C7C=CC (=C8C=CC (=C9C=CC (=C1C=C2) C=C9) C=C8) C=C7) C=C6) C=C5) C=C4) C=C3. InChI=1S/C48H32/c1-2-34-4-3-33 (1)35-5-7-37 (8-6-35)39-13-15-41 (16-14-39)43-21-23-45 (24-22-43)47-29-31-48 (32-30-47)46-27-25-44 (26-28-46)42-19-17-40 (18-20-42)38-11-9-36 (34)10-12-38/h1-32H. KOSJMHFAWQDZFH-UHFFFAOYSA-N. | |
| 8% Yttria Stabilized Zirconia | 8% Yttria Stabilized Zirconia. Group: Ceramic materials. CAS No. 114168-16-0. | |
| 9,10-Bis(3,5-dihydroxyphenyl)anthracene | 9,10-Bis(3,5-dihydroxyphenyl)anthracene. Group: Small molecule semiconductor building blocksmonomerssemiconductor blocks. CAS No. 153715-08-3. Product ID: 5-[10-(3,5-dihydroxyphenyl)anthracen-9-yl]benzene-1,3-diol. Molecular formula: 394.4g/mol. Mole weight: C26H18O4. C1=CC=C2C (=C1)C (=C3C=CC=CC3=C2C4=CC (=CC (=C4)O)O)C5=CC (=CC (=C5)O)O. InChI=1S/C26H18O4/c27-17-9-15 (10-18 (28)13-17)25-21-5-1-2-6-22 (21)26 (24-8-4-3-7-23 (24)25)16-11-19 (29)14-20 (30)12-16/h1-14, 27-30H. BTBBWVMITMIXSY-UHFFFAOYSA-N. >96.0%(LC). | |
| 9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene | 9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene. Group: Small molecule semiconductor building blocks. CAS No. 863992-56-7. Product ID: 4,4,5,5-tetramethyl-2-[10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracen-9-yl]-1,3,2-dioxaborolane. Molecular formula: 430.2g/mol. Mole weight: C26H32B2O4. B1 (OC (C (O1) (C)C) (C)C)C2=C3C=CC=CC3=C (C4=CC=CC=C24)B5OC (C (O5) (C)C) (C)C. InChI=1S/C26H32B2O4/c1-23 (2)24 (3, 4)30-27 (29-23)21-17-13-9-11-15-19 (17)22 (20-16-12-10-14-18 (20)21)28-31-25 (5, 6)26 (7, 8)32-28/h9-16H, 1-8H3. ZLXSWNVYGSZXOP-UHFFFAOYSA-N. | |
| 9,10-Bis(4-methoxyphenyl)anthracene | 9,10-Bis(4-methoxyphenyl)anthracene. Group: Small molecule semiconductor building blocksorganic light-emitting diode (oled) materials semiconductor blocks. Alternative Names: Anthracene,9,10-Bis(4-Methoxyphenyl)-. CAS No. 24672-76-2. Product ID: 9,10-bis(4-methoxyphenyl)anthracene. Molecular formula: 390.48. Mole weight: C28H22O2. COC1=CC=C (C=C1)C2=C3C=CC=CC3=C (C4=CC=CC=C42)C5=CC=C (C=C5)OC. InChI=1S/C28H22O2/c1-29-21-15-11-19 (12-16-21)27-23-7-3-5-9-25 (23)28 (26-10-6-4-8-24 (26)27)20-13-17-22 (30-2)18-14-20/h3-18H, 1-2H3. KTYCXBAOXVVIMM-UHFFFAOYSA-N. 95%+. | |
| 9,10-Bis(6-methoxy-2-naphthyl)anthracene | 9,10-Bis(6-methoxy-2-naphthyl)anthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 235099-48-6. Product ID: 9,10-bis(6-methoxynaphthalen-2-yl)anthracene. Molecular formula: 490.6g/mol. Mole weight: C36H26O2. COC1=CC2=C (C=C1)C=C (C=C2)C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC7=C (C=C6)C=C (C=C7)OC. InChI=1S / C36H26O2 / c1-37-29-17-15-23-19-27 (13-11-25 (23) 21-29) 35-31-7-3-5-9-33 (31) 36 (34-10-6-4-8-32 (34) 35) 28-14-12-26-22-30 (38-2) 18-16-24 (26) 20-28 / h3-22H, 1-2H3. VEVBQRGODPIBNJ-UHFFFAOYSA-N. | |
| 9,10-Bis(chloromethyl)anthracene | 9,10-Bis(chloromethyl)anthracene. Group: Small molecule semiconductor building blocks. CAS No. 10387-13-0. Product ID: 9,10-bis(chloromethyl)anthracene. Molecular formula: 275.2g/mol. Mole weight: C16H12Cl2. C1=CC=C2C (=C1)C (=C3C=CC=CC3=C2CCl)CCl. InChI=1S / C16H12Cl2 / c17-9-15-11-5-1-2-6-12 (11) 16 (10-18) 14-8-4-3-7-13 (14) 15 / h1-8H, 9-10H2. UOSROERWQJTVNU-UHFFFAOYSA-N. | |
| 9,10-Di(1-naphthyl)anthracene (purified by sublimation) | 9,10-Di(1-naphthyl)anthracene (purified by sublimation). Group: other material building blocksorganic light-emitting diode (oled) materials. Alternative Names: 9,10-Di(1-naphthayl)anthracene (purified by sublimation). CAS No. 26979-27-1. Product ID: 9,10-dinaphthalen-1-ylanthracene. Molecular formula: 430.55. Mole weight: C34H22. C1=CC=C2C (=C1)C=CC=C2C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC=CC7=CC=CC=C76. InChI=1S/C34H22/c1-3-15-25-23 (11-1)13-9-21-27 (25)33-29-17-5-7-19-31 (29)34 (32-20-8-6-18-30 (32)33)28-22-10-14-24-12-2-4-16-26 (24)28/h1-22H. GWNJZSGBZMLRBW-UHFFFAOYSA-N. >99.0%(HPLC). | |
| 9,10-Di(2-naphthyl)anthracene | 9,10-Di(2-naphthyl)anthracene. Group: Carbon nano materials organic light-emitting diode (oled) materials. CAS No. 122648-99-1. Product ID: 9,10-dinaphthalen-2-ylanthracene. Molecular formula: 430.5g/mol. Mole weight: C34H22. C1=CC=C2C=C (C=CC2=C1)C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC7=CC=CC=C7C=C6. InChI=1S/C34H22/c1-3-11-25-21-27 (19-17-23 (25)9-1)33-29-13-5-7-15-31 (29)34 (32-16-8-6-14-30 (32)33)28-20-18-24-10-2-4-12-26 (24)22-28/h1-22H. VIZUPBYFLORCRA-UHFFFAOYSA-N. | |
| 9,10-Di(2-naphthyl)anthracene (purified by sublimation) | 9,10-Di(2-naphthyl)anthracene (purified by sublimation). Group: other material building blocksorganic light-emitting diode (oled) materials. Alternative Names: 9,10-Di(2-naphthayl)anthracene. CAS No. 122648-99-1. Product ID: 9,10-dinaphthalen-2-ylanthracene. Molecular formula: 430.55. Mole weight: C34H22. C1=CC=C2C=C (C=CC2=C1)C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC7=CC=CC=C7C=C6. InChI=1S/C34H22/c1-3-11-25-21-27 (19-17-23 (25)9-1)33-29-13-5-7-15-31 (29)34 (32-16-8-6-14-30 (32)33)28-20-18-24-10-2-4-12-26 (24)22-28/h1-22H. VIZUPBYFLORCRA-UHFFFAOYSA-N. >99.0%(HPLC). | |
| 9,10-Dihydro-9,9-dimethylacridine | 9,10-Dihydro-9,9-dimethylacridine. Group: Small molecule semiconductor building blocksorganic light-emitting diode (oled) materials semiconductor blocks. CAS No. 6267-2-3. Product ID: 9,9-dimethyl-10H-acridine. Molecular formula: 209.29g/mol. Mole weight: C15H15N. CC1(C2=CC=CC=C2NC3=CC=CC=C31)C. InChI=1S/C15H15N/c1-15 (2)11-7-3-5-9-13 (11)16-14-10-6-4-8-12 (14)15/h3-10, 16H, 1-2H3. JSEQNGYLWKBMJI-UHFFFAOYSA-N. | |
| 9,10-Diphenylanthracene (purified by sublimation) | 9,10-Diphenylanthracene (purified by sublimation). Group: other material building blockscarbon nano materials organic light-emitting diode (oled) materials. CAS No. 1499-10-1. Product ID: 9,10-diphenylanthracene. Molecular formula: 330.4g/mol. Mole weight: C26H18. C1=CC=C (C=C1)C2=C3C=CC=CC3=C (C4=CC=CC=C42)C5=CC=CC=C5. InChI=1S/C26H18/c1-3-11-19 (12-4-1)25-21-15-7-9-17-23 (21)26 (20-13-5-2-6-14-20)24-18-10-8-16-22 (24)25/h1-18H. FCNCGHJSNVOIKE-UHFFFAOYSA-N. | |
| 9,10-Phenanthrenequinone | 9,10-Phenanthrenequinone. Group: Ligands for functional metal complexeselectroluminescence materials organic light-emitting diode (oled) materials other materials polymerization reagents. Alternative Names: 9,10-Phenanthrenedione. CAS No. 84-11-7. Pack Sizes: 5, 25 g in glass bottle. Product ID: phenanthrene-9,10-dione. Molecular formula: 208.21. Mole weight: C14H8O2. O=C1C(=O)C2=C(C=CC=C2)C2=CC=CC=C12. InChI=1S/C14H8O2/c15-13-11-7-3-1-5-9 (11)10-6-2-4-8-12 (10)14 (13)16/h1-8H. YYVYAPXYZVYDHN-UHFFFAOYSA-N. 98%. | |
| 9-([1,1'-Biphenyl]-3-yl)-10-bromoanthracene | 9-([1,1'-Biphenyl]-3-yl)-10-bromoanthracene. Group: Small molecule semiconductor building blocks. CAS No. 844679-02-3. Product ID: 9-bromo-10-(3-phenylphenyl)anthracene. Molecular formula: 409.3g/mol. Mole weight: C26H17Br. C1=CC=C (C=C1)C2=CC (=CC=C2)C3=C4C=CC=CC4=C (C5=CC=CC=C53)Br. InChI=1S / C26H17Br / c27-26-23-15-6-4-13-21 (23) 25 (22-14-5-7-16-24 (22) 26) 20-12-8-11-19 (17-20) 18-9-2-1-3-10-18 / h1-17H. WCMCZLIOCXISPX-UHFFFAOYSA-N. | |
| 9-([1,1'-Biphenyl]-3-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | 9-([1,1'-Biphenyl]-3-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1533406-38-0. Product ID: 9-(3-phenylphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole. Molecular formula: 445.4g/mol. Mole weight: C30H28BNO2. B1 (OC (C (O1) (C)C) (C)C)C2=CC3=C (C=C2)N (C4=CC=CC=C43)C5=CC=CC (=C5)C6=CC=CC=C6. InChI=1S/C30H28BNO2/c1-29 (2)30 (3, 4)34-31 (33-29)23-17-18-28-26 (20-23)25-15-8-9-16-27 (25)32 (28)24-14-10-13-22 (19-24)21-11-6-5-7-12-21/h5-20H, 1-4H3. VQLXKJLKLNGTQF-UHFFFAOYSA-N. | |
| 9-([1,1'-Biphenyl]-3-yl)-9H-carbazole | 9-([1,1'-Biphenyl]-3-yl)-9H-carbazole. Group: Small molecule semiconductor building blocks. CAS No. 1221237-87-1. Product ID: 9-(3-phenylphenyl)carbazole. Molecular formula: 319.4g/mol. Mole weight: C24H17N. C1=CC=C (C=C1)C2=CC (=CC=C2)N3C4=CC=CC=C4C5=CC=CC=C53. InChI=1S/C24H17N/c1-2-9-18 (10-3-1)19-11-8-12-20 (17-19)25-23-15-6-4-13-21 (23)22-14-5-7-16-24 (22)25/h1-17H. LKXFMLDAUIXMGY-UHFFFAOYSA-N. | |
| 9-([1,1'-Biphenyl]-4-yl)-10-bromo-2-phenylanthracene | 9-([1,1'-Biphenyl]-4-yl)-10-bromo-2-phenylanthracene. Group: Small molecule semiconductor building blocks. CAS No. 1195975-03-1. Product ID: 10-bromo-2-phenyl-9-(4-phenylphenyl)anthracene. Molecular formula: 485.4g/mol. Mole weight: C32H21Br. C1=CC=C (C=C1)C2=CC=C (C=C2)C3=C4C=C (C=CC4=C (C5=CC=CC=C53)Br)C6=CC=CC=C6. InChI=1S / C32H21Br / c33-32-28-14-8-7-13-27 (28) 31 (25-17-15-24 (16-18-25) 22-9-3-1-4-10-22) 30-21-26 (19-20-29 (30) 32) 23-11-5-2-6-12-23 / h1-21H. NGUZRYYKSIYQOV-UHFFFAOYSA-N. | |
| 9-([1,1'-Biphenyl]-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | 9-([1,1'-Biphenyl]-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1391729-66-0. Product ID: 9-(4-phenylphenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole. Molecular formula: 445.4g/mol. Mole weight: C30H28BNO2. B1 (OC (C (O1) (C)C) (C)C)C2=CC3=C (C=C2)N (C4=CC=CC=C43)C5=CC=C (C=C5)C6=CC=CC=C6. InChI=1S/C30H28BNO2/c1-29 (2)30 (3, 4)34-31 (33-29)23-16-19-28-26 (20-23)25-12-8-9-13-27 (25)32 (28)24-17-14-22 (15-18-24)21-10-6-5-7-11-21/h5-20H, 1-4H3. ZQVXGZDSERJQTC-UHFFFAOYSA-N. | |
| 9-([1,1'-Biphenyl]-4-yl)anthracene | 9-([1,1'-Biphenyl]-4-yl)anthracene. Group: Small molecule semiconductor building blocks. CAS No. 323195-31-9. Product ID: 9-(4-phenylphenyl)anthracene. Molecular formula: 330.4g/mol. Mole weight: C26H18. C1=CC=C (C=C1)C2=CC=C (C=C2)C3=C4C=CC=CC4=CC5=CC=CC=C53. InChI=1S/C26H18/c1-2-8-19 (9-3-1)20-14-16-21 (17-15-20)26-24-12-6-4-10-22 (24)18-23-11-5-7-13-25 (23)26/h1-18H. ZPLVQJGIYNHPIG-UHFFFAOYSA-N. | |
| 9-(1-Naphthyl)anthracene | 9-(1-Naphthyl)anthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 7424-70-6. Product ID: 9-naphthalen-1-ylanthracene. Molecular formula: 304.39. Mole weight: C24H16. C1=CC=C2C (=C1) C=CC=C2C3=C4C=CC=CC4=CC5=CC=CC=C53. InChI=1S/C24H16/c1-4-12-20-17 (8-1)11-7-15-23 (20)24-21-13-5-2-9-18 (21)16-19-10-3-6-14-22 (19)24/h1-16H. YPNZWHZIYLWEDR-UHFFFAOYSA-N. >98.0%(GC). | |
| 9-(1-Naphthyl)carbazole | 9-(1-Naphthyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 22034-43-1. Product ID: 9-naphthalen-1-ylcarbazole. Molecular formula: 293.37. Mole weight: C22H15N. C1=CC=C2C (=C1) C=CC=C2N3C4=CC=CC=C4C5=CC=CC=C53. InChI=1S/C22H15N/c1-2-10-17-16 (8-1)9-7-15-20 (17)23-21-13-5-3-11-18 (21)19-12-4-6-14-22 (19)23/h1-15H. QSOAYCUFEQGHDN-UHFFFAOYSA-N. >98.0%(GC). | |
| 9-(2-Biphenylyl)-10-bromoanthracene | 9-(2-Biphenylyl)-10-bromoanthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 400607-16-1. Product ID: 9-bromo-10-(2-phenylphenyl)anthracene. Molecular formula: 409.3g/mol. Mole weight: C26H17Br. C1=CC=C (C=C1)C2=CC=CC=C2C3=C4C=CC=CC4=C (C5=CC=CC=C53)Br. InChI=1S / C26H17Br / c27-26-23-16-8-6-14-21 (23) 25 (22-15-7-9-17-24 (22) 26) 20-13-5-4-12-19 (20) 18-10-2-1-3-11-18 / h1-17H. NANUBXRTTQXXDS-UHFFFAOYSA-N. | |
| 9-(2'-Bromo-4-biphenylyl)carbazole | 9-(2'-Bromo-4-biphenylyl)carbazole. Group: Small molecule semiconductor building blocks. CAS No. 1215228-57-1. Product ID: 9-[4-(2-bromophenyl)phenyl]carbazole. Molecular formula: 398.3g/mol. Mole weight: C24H16BrN. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=C (C=C4)C5=CC=CC=C5Br. InChI=1S / C24H16BrN / c25-22-10-4-1-7-19 (22) 17-13-15-18 (16-14-17) 26-23-11-5-2-8-20 (23) 21-9-3-6-12-24 (21) 26 / h1-16H. IPJQGEJRMPUZEW-UHFFFAOYSA-N. | |
| 9-(2-Bromophenyl)-9H-carbazole | 9-(2-Bromophenyl)-9H-carbazole. Group: Small molecule semiconductor building blocksorganic light-emitting diode (oled) materials other electronic materials. CAS No. 902518-11-0. Product ID: 9-(2-bromophenyl)carbazole. Molecular formula: 322.2g/mol. Mole weight: C18H12BrN. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=CC=C4Br. InChI=1S / C18H12BrN / c19-15-9-3-6-12-18 (15) 20-16-10-4-1-7-13 (16) 14-8-2-5-11-17 (14) 20 / h1-12H. KEWDVYIULXXMPP-UHFFFAOYSA-N. | |
| 9-(2-Ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | 9-(2-Ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole. Group: Small molecule semiconductor building blockspolymers. Alternative Names: 9-(2-Ethylhexyl)-9H-carbazole-2,7-diboronic Acid Bis(pinacol) Ester. CAS No. 476360-83-5. Product ID: 9-(2-ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole. Molecular formula: 531.35. Mole weight: C32H47B2NO4. B1 (OC (C (O1) (C)C) (C)C)C2=CC3=C (C=C2)C4=C (N3CC (CC)CCCC)C=C (C=C4)B5OC (C (O5) (C)C) (C)C. InChI=1S/C32H47B2NO4/c1-11-13-14-22 (12-2)21-35-27-19-23 (33-36-29 (3, 4)30 (5, 6)37-33)15-17-25 (27)26-18-16-24 (20-28 (26)35)34-38-31 (7, 8)32 (9, 10)39-34/h15-20, 22H, 11-14, 21H2, 1-10H3. MQUNOJWYLQJTOL-UHFFFAOYSA-N. >98.0%(T)(HPLC). | |
| 9-(2-Ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 98% | 9-(2-Ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 98%. Group: other glass and ceramic materials. CAS No. 476360-83-5. Product ID: 9-(2-ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole. Molecular formula: 531.3g/mol. Mole weight: C32H47B2NO4. B1 (OC (C (O1) (C)C) (C)C)C2=CC3=C (C=C2)C4=C (N3CC (CC)CCCC)C=C (C=C4)B5OC (C (O5) (C)C) (C)C. InChI=1S/C32H47B2NO4/c1-11-13-14-22 (12-2)21-35-27-19-23 (33-36-29 (3, 4)30 (5, 6)37-33)15-17-25 (27)26-18-16-24 (20-28 (26)35)34-38-31 (7, 8)32 (9, 10)39-34/h15-20, 22H, 11-14, 21H2, 1-10H3. MQUNOJWYLQJTOL-UHFFFAOYSA-N. | |
| 9-(2-Ethylhexyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole | 9-(2-Ethylhexyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole. Group: Small molecule semiconductor building blocks. CAS No. 856422-41-8. Product ID: 9-(2-ethylhexyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole. Molecular formula: 405.4g/mol. Mole weight: C26H36BNO2. B1 (OC (C (O1) (C)C) (C)C)C2=CC3=C (C=C2)N (C4=CC=CC=C43)CC (CC)CCCC. InChI=1S/C26H36BNO2/c1-7-9-12-19 (8-2)18-28-23-14-11-10-13-21 (23)22-17-20 (15-16-24 (22)28)27-29-25 (3, 4)26 (5, 6)30-27/h10-11, 13-17, 19H, 7-9, 12, 18H2, 1-6H3. FJWSYCLXMVHHPL-UHFFFAOYSA-N. | |
| 9-(2-Ethylhexyl)carbazole | 9-(2-Ethylhexyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 187148-77-2. Product ID: 9-(2-ethylhexyl)carbazole. Molecular formula: 279.4g/mol. Mole weight: C20H25N. CCCCC(CC)CN1C2=CC=CC=C2C3=CC=CC=C31. InChI=1S/C20H25N/c1-3-5-10-16 (4-2)15-21-19-13-8-6-11-17 (19)18-12-7-9-14-20 (18)21/h6-9, 11-14, 16H, 3-5, 10, 15H2, 1-2H3. SAXNQWFLHXTRDI-UHFFFAOYSA-N. | |
| 9-(2-Naphthyl)anthracene | 9-(2-Naphthyl)anthracene. Group: Small molecule semiconductor building blocks. CAS No. 7424-72-8. Product ID: 9-naphthalen-2-ylanthracene. Molecular formula: 304.4g/mol. Mole weight: C24H16. C1=CC=C2C=C (C=CC2=C1) C3=C4C=CC=CC4=CC5=CC=CC=C53. InChI=1S/C24H16/c1-2-8-18-15-21 (14-13-17 (18)7-1)24-22-11-5-3-9-19 (22)16-20-10-4-6-12-23 (20)24/h1-16H. MFDORGWIGJJZEQ-UHFFFAOYSA-N. | |
| 9-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbazole | 9-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 870119-58-7. Product ID: 9-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbazole. Molecular formula: 369.3g/mol. Mole weight: C24H24BNO2. B1 (OC (C (O1) (C)C) (C)C)C2=CC (=CC=C2)N3C4=CC=CC=C4C5=CC=CC=C53. InChI=1S/C24H24BNO2/c1-23 (2)24 (3, 4)28-25 (27-23)17-10-9-11-18 (16-17)26-21-14-7-5-12-19 (21)20-13-6-8-15-22 (20)26/h5-16H, 1-4H3. YWLGYAZJWNLVKB-UHFFFAOYSA-N. | |
| 9-(3,5-Dibromophenyl)carbazole | 9-(3,5-Dibromophenyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 750573-26-3. Product ID: 9-(3,5-dibromophenyl)carbazole. Molecular formula: 401.1g/mol. Mole weight: C18H11Br2N. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC (=CC (=C4)Br)Br. InChI=1S/C18H11Br2N/c19-12-9-13 (20)11-14 (10-12)21-17-7-3-1-5-15 (17)16-6-2-4-8-18 (16)21/h1-11H. YXHXRBIAIVNCPG-UHFFFAOYSA-N. | |
| 9,3':6',9''-Tercarbazole | 9,3':6',9''-Tercarbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 606129-90-2. Product ID: 3,6-di(carbazol-9-yl)-9H-carbazole. Molecular formula: 497.6g/mol. Mole weight: C36H23N3. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC5=C (C=C4)NC6=C5C=C (C=C6)N7C8=CC=CC=C8C9=CC=CC=C97. InChI=1S/C36H23N3/c1-5-13-33-25 (9-1)26-10-2-6-14-34 (26)38 (33)23-17-19-31-29 (21-23)30-22-24 (18-20-32 (30)37-31)39-35-15-7-3-11-27 (35)28-12-4-8-16-36 (28)39/h1-22, 37H. OGDZAJUZGODBKX-UHFFFAOYSA-N. | |
| 9-(3-Biphenylyl)-3-bromocarbazole | 9-(3-Biphenylyl)-3-bromocarbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1428551-28-3. Product ID: 3-bromo-9-(3-phenylphenyl)carbazole. Molecular formula: 398.3g/mol. Mole weight: C24H16BrN. C1=CC=C (C=C1)C2=CC (=CC=C2)N3C4=C (C=C (C=C4)Br)C5=CC=CC=C53. InChI=1S / C24H16BrN / c25-19-13-14-24-22 (16-19) 21-11-4-5-12-23 (21) 26 (24) 20-10-6-9-18 (15-20) 17-7-2-1-3-8-17 / h1-16H. NSRPRPVECXNOLB-UHFFFAOYSA-N. | |
| 9-(3-Bromophenyl)-10-phenylanthracene | 9-(3-Bromophenyl)-10-phenylanthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1023674-80-7. Product ID: 9-(3-bromophenyl)-10-phenylanthracene. Molecular formula: 409.3g/mol. Mole weight: C26H17Br. C1=CC=C (C=C1)C2=C3C=CC=CC3=C (C4=CC=CC=C42)C5=CC (=CC=C5)Br. InChI=1S/C26H17Br/c27-20-12-8-11-19 (17-20)26-23-15-6-4-13-21 (23)25 (18-9-2-1-3-10-18)22-14-5-7-16-24 (22)26/h1-17H. KHPNWZVLPLJEHH-UHFFFAOYSA-N. | |
| 9-(3-bromophenyl)-9-phenyl-9H-fluorene | 9-(3-bromophenyl)-9-phenyl-9H-fluorene. Group: Small molecule semiconductor building blocks other electronic materials. Alternative Names: 9H-Fluorene,9-(3-bromophenyl)-9-phenyl-. CAS No. 1257251-75-4. Product ID: 9-(3-bromophenyl)-9-phenylfluorene. Molecular formula: 397.31. Mole weight: C25H17Br. C1=CC=C (C=C1)C2 (C3=CC=CC=C3C4=CC=CC=C42)C5=CC (=CC=C5)Br. InChI=1S/C25H17Br/c26-20-12-8-11-19 (17-20)25 (18-9-2-1-3-10-18)23-15-6-4-13-21 (23)22-14-5-7-16-24 (22)25/h1-17H. LWBYEDXZPBXTFL-UHFFFAOYSA-N. 95%+. | |
| 9-(3-Bromophenyl)carbazole | 9-(3-Bromophenyl)carbazole. Group: Small molecule semiconductor building blocks other electronic materials. Alternative Names: N-(3-BroMophenyl)carbazole. CAS No. 185112-61-2. Product ID: 9-(3-bromophenyl)carbazole. Molecular formula: 322.20. Mole weight: C18H12BrN. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC (=CC=C4)Br. ZKGHGKNHPPZALY-UHFFFAOYSA-N. InChI=1S/C18H12BrN/c19-13-6-5-7-14 (12-13)20-17-10-3-1-8-15 (17)16-9-2-4-11-18 (16)20/h1-12H. 98%. | |
| 9-[3-(Dibenzofuran-2-yl)phenyl]-9H-carbazole | 9-[3-(Dibenzofuran-2-yl)phenyl]-9H-carbazole. Group: Electronic materials organic light-emitting diode (oled) materials. Alternative Names: 9-(3-Dibenzofuran-2-Ylphenyl)Carbazole. CAS No. 1338446-77-7. Product ID: 9-(3-dibenzofuran-2-ylphenyl)carbazole. Molecular formula: 409.49. Mole weight: C30H19NO. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=CC (=C4)C5=CC6=C (C=C5)OC7=CC=CC=C76. InChI=1S/C30H19NO/c1-4-13-27-23 (10-1)24-11-2-5-14-28 (24)31 (27)22-9-7-8-20 (18-22)21-16-17-30-26 (19-21)25-12-3-6-15-29 (25)32-30/h1-19H. YEWVLWWLYHXZLZ-UHFFFAOYSA-N. 95%+. | |
| 9-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole | 9-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole. Group: Small molecule semiconductor building blocks. CAS No. 785051-54-9. Product ID: 9-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbazole. Molecular formula: 369.3g/mol. Mole weight: C24H24BNO2. B1 (OC (C (O1) (C)C) (C)C)C2=CC=C (C=C2)N3C4=CC=CC=C4C5=CC=CC=C53. InChI=1S/C24H24BNO2/c1-23 (2)24 (3, 4)28-25 (27-23)17-13-15-18 (16-14-17)26-21-11-7-5-9-19 (21)20-10-6-8-12-22 (20)26/h5-16H, 1-4H3. AHDSYMVAUJZCOP-UHFFFAOYSA-N. | |
| 9-(4-Biphenylyl)-10-bromoanthracene | 9-(4-Biphenylyl)-10-bromoanthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 400607-05-8. Product ID: 9-bromo-10-(4-phenylphenyl)anthracene. Molecular formula: 409.3g/mol. Mole weight: C26H17Br. C1=CC=C (C=C1)C2=CC=C (C=C2)C3=C4C=CC=CC4=C (C5=CC=CC=C53)Br. InChI=1S / C26H17Br / c27-26-23-12-6-4-10-21 (23) 25 (22-11-5-7-13-24 (22) 26) 20-16-14-19 (15-17-20) 18-8-2-1-3-9-18 / h1-17H. VCJIOUBBOCVHPE-UHFFFAOYSA-N. | |
| 9-(4-Biphenylyl)-2-bromocarbazole | 9-(4-Biphenylyl)-2-bromocarbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1393835-87-4. Product ID: 2-bromo-9-(4-phenylphenyl)carbazole. Molecular formula: 398.3g/mol. Mole weight: C24H16BrN. C1=CC=C (C=C1)C2=CC=C (C=C2)N3C4=CC=CC=C4C5=C3C=C (C=C5)Br. InChI=1S / C24H16BrN / c25-19-12-15-22-21-8-4-5-9-23 (21) 26 (24 (22) 16-19) 20-13-10-18 (11-14-20) 17-6-2-1-3-7-17 / h1-16H. WNJONVVVRMCDDZ-UHFFFAOYSA-N. | |
| 9-(4-Biphenylyl)-3-(4-bromophenyl)carbazole | 9-(4-Biphenylyl)-3-(4-bromophenyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1028648-25-0. Product ID: 3-(4-bromophenyl)-9-(4-phenylphenyl)carbazole. Molecular formula: 474.4g/mol. Mole weight: C30H20BrN. C1=CC=C (C=C1)C2=CC=C (C=C2)N3C4=C (C=C (C=C4)C5=CC=C (C=C5)Br)C6=CC=CC=C63. InChI=1S/C30H20BrN/c31-25-15-10-23 (11-16-25)24-14-19-30-28 (20-24)27-8-4-5-9-29 (27)32 (30)26-17-12-22 (13-18-26)21-6-2-1-3-7-21/h1-20H. AZGVZMFTHCOVID-UHFFFAOYSA-N. | |
| 9-(4-Biphenylyl)-3-bromocarbazole | 9-(4-Biphenylyl)-3-bromocarbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 894791-46-9. Product ID: 3-bromo-9-(4-phenylphenyl)carbazole. Molecular formula: 398.3g/mol. Mole weight: C24H16BrN. C1=CC=C (C=C1)C2=CC=C (C=C2)N3C4=C (C=C (C=C4)Br)C5=CC=CC=C53. InChI=1S / C24H16BrN / c25-19-12-15-24-22 (16-19) 21-8-4-5-9-23 (21) 26 (24) 20-13-10-18 (11-14-20) 17-6-2-1-3-7-17 / h1-16H. MOCNGNGLTRMQQH-UHFFFAOYSA-N. | |
| 9-(4-Biphenylyl)carbazole | 9-(4-Biphenylyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 6299-16-7. Product ID: 9-(4-phenylphenyl)carbazole. Molecular formula: 319.4g/mol. Mole weight: C24H17N. C1=CC=C (C=C1)C2=CC=C (C=C2)N3C4=CC=CC=C4C5=CC=CC=C53. InChI=1S/C24H17N/c1-2-8-18 (9-3-1)19-14-16-20 (17-15-19)25-23-12-6-4-10-21 (23)22-11-5-7-13-24 (22)25/h1-17H. DQMMBEPJQZXXGK-UHFFFAOYSA-N. | |
| 9-(4'-Bromo-4-biphenylyl)carbazole | 9-(4'-Bromo-4-biphenylyl)carbazole. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 212385-73-4. Product ID: 9-[4-(4-bromophenyl)phenyl]carbazole. Molecular formula: 398.3g/mol. Mole weight: C24H16BrN. C1=CC=C2C (=C1)C3=CC=CC=C3N2C4=CC=C (C=C4)C5=CC=C (C=C5)Br. InChI=1S/C24H16BrN/c25-19-13-9-17 (10-14-19)18-11-15-20 (16-12-18)26-23-7-3-1-5-21 (23)22-6-2-4-8-24 (22)26/h1-16H. OGENPBMBOLTWLZ-UHFFFAOYSA-N. | |
| 9-(4-Bromobutyl)-9H-carbazole | 9-(4-Bromobutyl)-9H-carbazole. Group: Small molecule semiconductor building blocks. CAS No. 10420-20-9. Product ID: 9-(4-bromobutyl)carbazole. Molecular formula: 302.21g/mol. Mole weight: C16H16BrN. C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCBr. InChI=1S / C16H16BrN / c17-11-5-6-12-18-15-9-3-1-7-13 (15) 14-8-2-4-10-16 (14) 18 / h1-4, 7-10H, 5-6, 11-12H2. IXCQFUSWIBGIQG-UHFFFAOYSA-N. | |
| 9-(4-Bromophenyl)-10-(1-naphthyl)anthracene | 9-(4-Bromophenyl)-10-(1-naphthyl)anthracene. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1160506-32-0. Product ID: 9-(4-bromophenyl)-10-naphthalen-1-ylanthracene. Molecular formula: 459.4g/mol. Mole weight: C30H19Br. C1=CC=C2C (=C1)C=CC=C2C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC=C (C=C6)Br. InChI=1S/C30H19Br/c31-22-18-16-21 (17-19-22)29-25-11-3-5-13-27 (25)30 (28-14-6-4-12-26 (28)29)24-15-7-9-20-8-1-2-10-23 (20)24/h1-19H. DMAFDYCUZMVPNZ-UHFFFAOYSA-N. | |
| 9-(4-Bromophenyl)-10-(2-naphthyl)anthracene | 9-(4-Bromophenyl)-10-(2-naphthyl)anthracene. Group: Small molecule semiconductor building blocks. CAS No. 936854-62-5. Product ID: 9-(4-bromophenyl)-10-naphthalen-2-ylanthracene. Molecular formula: 459.4g/mol. Mole weight: C30H19Br. C1=CC=C2C=C (C=CC2=C1)C3=C4C=CC=CC4=C (C5=CC=CC=C53)C6=CC=C (C=C6)Br. InChI=1S/C30H19Br/c31-24-17-15-21 (16-18-24)29-25-9-3-5-11-27 (25)30 (28-12-6-4-10-26 (28)29)23-14-13-20-7-1-2-8-22 (20)19-23/h1-19H. MWIMXPOBAUIYCW-UHFFFAOYSA-N. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.